propiverine has been researched along with Urinary Bladder, Neurogenic in 20 studies
propiverine: anticholinergic used for overactive bladder syndrome
Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propiverine hydrochloride was given to patients with subjective symptoms of urinary incontinence and its effect was evaluated in relation to the pathogenesis of incontinence." | 9.08 | [Clinical effect of propiverine hydrochloride on urinary incontinence]. ( Kojima, M; Uchida, M; Watanabe, H, 1998) |
| "Propiverine is a well established antimuscarinic agent with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB)." | 6.49 | Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. ( McKeage, K, 2013) |
| "Propiverine hydrochloride was given to patients with subjective symptoms of urinary incontinence and its effect was evaluated in relation to the pathogenesis of incontinence." | 5.08 | [Clinical effect of propiverine hydrochloride on urinary incontinence]. ( Kojima, M; Uchida, M; Watanabe, H, 1998) |
| "or oxybutynin 5mg t." | 2.73 | Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study. ( Arnold, EP; Kramer, G; Mürtz, G; Schnabel, F; Stöhrer, M; Wyndaele, JJ, 2007) |
| " For the evaluation of the safety of propiverine the incidence rate of adverse events by directly questioning as well as laboratory parameters were investigated." | 2.69 | Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial. ( Dreikorn, K; Madersbacher, H; Richter, R; Stöhrer, M; Wehnert, J, 1999) |
| " The application period was 4 weeks and the dosage was 45 mg/d Mictonorm and 300 mg/d Spasuret, respectively." | 2.66 | [Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle]. ( Sage, S; Wehnert, J, 1989) |
| "Propiverine is a well established antimuscarinic agent with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB)." | 2.49 | Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. ( McKeage, K, 2013) |
| " Voigt reported an adverse event incidence rate of 13% in a follow-up investigation during 10 years of treatment." | 2.41 | Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic). ( Madersbacher, H; Mürtz, G, 2001) |
| "Propiverine monotherapy was well tolerated in 11/17 patients." | 1.38 | Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study. ( Austin, P; Heine, G; Knispel, HH; Michael, T; Miller, K; Mürtz, G; Schulte-Baukloh, H; Strugala, G, 2012) |
| "Propiverine was better tolerated than oxybutynin, having fewer adverse drug reactions (9." | 1.35 | Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study. ( Alloussi, S; Bock, P; Domurath, B; Henne, T; Körner, I; Madersbacher, H; Mürtz, G; Niedeggen, A; Nounla, J; Pannek, J; Schulte-Baukloh, H; Schultz-Lampel, D; Strugala, G, 2009) |
| " The urodynamic measurements as well as pharmacokinetic samplings were done before the medication, 4 weeks and 8 weeks after the starting medication, to examine the dose-response and concentration-response relationships." | 1.33 | [Pharmacological evaluation of efficacy and safety of propiverine hydrochloride in patients of overactive bladder--relationship between urodynamic observation and propiverine pharmacokinetics--]. ( Hanai, T; Hashimoto, K; Matsumoto, S; Shimizu, N; Sugiyama, T; Uemura, H; Yoshioka, N, 2005) |
| "Propiverine hydrochloride is a preferable alternative to oxybutynin, the anticholinergic most frequently used in children with NDO to date." | 1.33 | Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis. ( Henne, T; Knispel, HH; Michael, T; Miller, K; Mürtz, G; Schulte-Baukloh, H, 2006) |
| " One patient spontaneously reported a typical anticholinergic adverse event, which resolved after dose reduction." | 1.33 | Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study. ( Goepel, M; Grigoleit, U; Kramer, G; Laschke, S; Mürtz, G; Schuldt, M; Stöhrer, M, 2006) |
| "To evaluate type of neurogenic bladder and to observe changes of autonomous detrusor contraction (ADC) after the normalization of the compliance and capacity of the bladder in cauda equina injury." | 1.31 | Significance of low compliance bladder in cauda equina injury. ( Kim, HJ; Lee, IY; Park, CI; Shin, JC, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Masumori, N | 1 |
| Funato, Y | 1 |
| Yamaguchi, Y | 1 |
| Itoh, K | 1 |
| Madersbacher, H | 3 |
| Mürtz, G | 7 |
| Alloussi, S | 1 |
| Domurath, B | 1 |
| Henne, T | 2 |
| Körner, I | 1 |
| Niedeggen, A | 1 |
| Nounla, J | 1 |
| Pannek, J | 1 |
| Schulte-Baukloh, H | 3 |
| Schultz-Lampel, D | 1 |
| Bock, P | 1 |
| Strugala, G | 3 |
| Heine, G | 1 |
| Austin, P | 1 |
| Miller, K | 2 |
| Michael, T | 2 |
| Knispel, HH | 2 |
| McKeage, K | 1 |
| Stöhrer, M | 4 |
| Kramer, G | 3 |
| Warnack, W | 1 |
| Primus, G | 1 |
| Jinga, V | 1 |
| Manu-Marin, A | 1 |
| Calomfirescu, N | 1 |
| Shin, JC | 1 |
| Park, CI | 1 |
| Kim, HJ | 1 |
| Lee, IY | 1 |
| Shimizu, I | 1 |
| Kawashima, K | 1 |
| Ishii, D | 1 |
| Oka, M | 1 |
| Suzuki, M | 1 |
| Ohtake, A | 1 |
| Yoshino, T | 1 |
| Yuyama, H | 1 |
| Hayashi, A | 1 |
| Ukai, M | 1 |
| Okutsu, H | 1 |
| Noguchi, Y | 1 |
| Sato, S | 1 |
| Sasamata, M | 1 |
| Sugiyama, T | 1 |
| Shimizu, N | 1 |
| Hashimoto, K | 1 |
| Yoshioka, N | 1 |
| Hanai, T | 1 |
| Matsumoto, S | 1 |
| Uemura, H | 1 |
| Grigoleit, U | 1 |
| Laschke, S | 1 |
| Schuldt, M | 1 |
| Goepel, M | 1 |
| Sahai, A | 1 |
| Khan, MS | 1 |
| Arya, M | 1 |
| John, J | 1 |
| Singh, R | 1 |
| Patel, HR | 1 |
| Schnabel, F | 1 |
| Arnold, EP | 1 |
| Wyndaele, JJ | 1 |
| Wehnert, J | 4 |
| Kelly, LU | 1 |
| Sage, S | 2 |
| Mazur, D | 1 |
| Göcking, K | 1 |
| Schubert, G | 1 |
| Herfurth, G | 1 |
| Alken, RG | 1 |
| Watanabe, H | 1 |
| Uchida, M | 1 |
| Kojima, M | 1 |
| Richter, R | 1 |
| Dreikorn, K | 1 |
| Pfestorf, B | 1 |
| Jaeger, HD | 1 |
| Schenk, EM | 1 |
3 reviews available for propiverine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.
Topics: Adolescent; Adult; Age Factors; Benzilates; Child; Child, Preschool; Drug Therapy, Combination; Fema | 2013 |
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Algorithms; Animals; | 2006 |
Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic).
Topics: Adult; Aged; Benzilates; Child; Humans; Muscarinic Antagonists; Muscle, Smooth; Urinary Bladder; Uri | 2001 |
6 trials available for propiverine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity.
Topics: Adolescent; Adult; Aged; Benzilates; Delayed-Action Preparations; Double-Blind Method; Female; Human | 2013 |
Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
Topics: Adolescent; Adult; Aged; Benzilates; Cholinergic Antagonists; Double-Blind Method; Female; Humans; M | 2007 |
[Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
Topics: Adolescent; Adult; Aged; Benzilates; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1994 |
[Clinical effect of propiverine hydrochloride on urinary incontinence].
Topics: Adult; Aged; Aged, 80 and over; Benzilates; Female; Humans; Male; Middle Aged; Parasympatholytics; U | 1998 |
Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
Topics: Adult; Benzilates; Double-Blind Method; Female; Humans; Male; Middle Aged; Parasympatholytics; Progn | 1999 |
[Comparative studies of the effect of mictonorm (propiverin hydrochloride) and Spasuret (flavoxate hydrochloride) on the bladder detrusor muscle].
Topics: Benzilates; Clinical Trials as Topic; Flavonoids; Flavoxate; Humans; Middle Aged; Parasympatholytics | 1989 |
11 other studies available for propiverine and Urinary Bladder, Neurogenic
| Article | Year |
|---|---|
Evaluation of Usefulness of Propiverine Hydrochloride in Poor Responders to Previous Anticholinergics.
Topics: Aged; Benzilates; Drug Administration Schedule; Drug Substitution; Female; Humans; Male; Medication | 2018 |
Propiverine vs oxybutynin for treating neurogenic detrusor overactivity in children and adolescents: results of a multicentre observational cohort study.
Topics: Adolescent; Benzilates; Child; Child, Preschool; Epidemiologic Methods; Female; Humans; Infant; Male | 2009 |
Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study.
Topics: Adolescent; Benzilates; Child; Child, Preschool; Cholinergic Antagonists; Cohort Studies; Cystoscopy | 2012 |
Significance of low compliance bladder in cauda equina injury.
Topics: Administration, Intravesical; Administration, Oral; Adult; Benzilates; Cauda Equina; Compliance; Fem | 2002 |
Urodynamics in a rat neurogenic bladder model with a unilateral electrolytic lesion of the basal forebrain.
Topics: Animals; Benzilates; Brain Diseases; Cholinergic Antagonists; Disease Models, Animal; Fumarates; Mal | 2003 |
Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
Topics: Animals; Benzhydryl Compounds; Benzilates; Cresols; Infarction, Middle Cerebral Artery; Male; Muscar | 2005 |
[Pharmacological evaluation of efficacy and safety of propiverine hydrochloride in patients of overactive bladder--relationship between urodynamic observation and propiverine pharmacokinetics--].
Topics: Aged; Benzilates; Female; Humans; Male; Parasympatholytics; Urinary Bladder, Neurogenic; Urinary Inc | 2005 |
Urodynamic effects of propiverine hydrochloride in children with neurogenic detrusor overactivity: a prospective analysis.
Topics: Adolescent; Benzilates; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Parasympatholytics | 2006 |
Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
Topics: Adolescent; Adult; Benzilates; Child; Child, Preschool; Cholinergic Antagonists; Female; Humans; Inf | 2006 |
[Therapy of detrusor hyperactivity with propiverin (mictonorm)].
Topics: Benzilates; Humans; Hydrostatic Pressure; Manometry; Muscle Contraction; Parasympatholytics; Urinary | 1981 |
[Cholinolytic treatment of pediatric bladder instability with Mictonetten].
Topics: Adolescent; Benzilates; Child; Child, Preschool; Female; Humans; Male; Parasympatholytics; Urinary B | 1986 |